These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 32739122)

  • 1. The evolving landscape of gene therapy for congenital haemophilia: An unprecedented, problematic but promising opportunity for worldwide clinical studies.
    Spadarella G; Di Minno A; Brunetti-Pierri N; Mahlangu J; Di Minno G
    Blood Rev; 2021 Mar; 46():100737. PubMed ID: 32739122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core outcome set for gene therapy in haemophilia: Results of the coreHEM multistakeholder project.
    Iorio A; Skinner MW; Clearfield E; Messner D; Pierce GF; Witkop M; Tunis S;
    Haemophilia; 2018 Jul; 24(4):e167-e172. PubMed ID: 29781145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gene therapy of haemophilia - has the cure come within reach?].
    Kaczmarek R
    Postepy Biochem; 2018 Dec; 64(4):318-322. PubMed ID: 30656916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress, and prospects in the therapeutic armamentarium of persons with congenital hemophilia. Defining the place for liver-directed gene therapy.
    Di Minno G; Castaman G; De Cristofaro R; Brunetti-Pierri N; Pastore L; Castaldo G; Trama U; Di Minno M
    Blood Rev; 2023 Mar; 58():101011. PubMed ID: 36031462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative payment models for durable and potentially curative therapies: The case of gene therapy for haemophilia A.
    Goodman C; Berntorp E; Wong O;
    Haemophilia; 2022 Mar; 28 Suppl 2():27-34. PubMed ID: 35060645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partnering to change the world for people with haemophilia: 7th Haemophilia Global Summit, Madrid, Spain 22-24 September 2016.
    Dolan G
    Eur J Haematol; 2017 Oct; 99 Suppl 87():3-9. PubMed ID: 28921738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for haemophilia A and B, from basic principles to clinical implementation: An illustrated review.
    Ay C; Frenzel L; Pinachyan K; Le Quellec S
    Haemophilia; 2024 Jan; 30(1):5-15. PubMed ID: 38111029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health technology assessment for gene therapies in haemophilia.
    O'Hara J; Neumann PJ;
    Haemophilia; 2022 Mar; 28 Suppl 2():19-26. PubMed ID: 35075731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to discuss gene therapy for haemophilia? A patient and physician perspective.
    Miesbach W; O'Mahony B; Key NS; Makris M
    Haemophilia; 2019 Jul; 25(4):545-557. PubMed ID: 31115117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemophilia B: Where are we now and what does the future hold?
    Dolan G; Benson G; Duffy A; Hermans C; Jiménez-Yuste V; Lambert T; Ljung R; Morfini M; Zupančić Šalek S
    Blood Rev; 2018 Jan; 32(1):52-60. PubMed ID: 28826659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemophilia gene therapy-New country initiatives.
    Reiss UM; Zhang L; Ohmori T
    Haemophilia; 2021 Feb; 27 Suppl 3():132-141. PubMed ID: 32638467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in developing specific therapies for haemophilia.
    Ling G; Nathwani AC; Tuddenham EGD
    Br J Haematol; 2018 Apr; 181(2):161-172. PubMed ID: 29359795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances and challenges for hemophilia gene therapy.
    Batty P; Lillicrap D
    Hum Mol Genet; 2019 Oct; 28(R1):R95-R101. PubMed ID: 31332444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradigm shift for the treatment of hereditary haemophilia: Towards precision medicine.
    Spadarella G; Di Minno A; Milan G; Franco N; Polimeno M; Castaldo F; Di Minno G
    Blood Rev; 2020 Jan; 39():100618. PubMed ID: 31676141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Awareness of individual goals, preferences, and priorities of persons with severe congenital haemophilia A for a tailored shared decision-making approach to liver-directed gene therapy. A practical guideline.
    Di Minno G; Spadarella G; Maldonato NM; De Lucia N; Castaman G; De Cristofaro R; Santoro C; Peyvandi F; Borrelli A; Lupi A; Follino M; Guerrino G; Morisco F; Di Minno M
    Blood Rev; 2023 Nov; 62():101118. PubMed ID: 37544828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemophilias A and B.
    Bolton-Maggs PH; Pasi KJ
    Lancet; 2003 May; 361(9371):1801-9. PubMed ID: 12781551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Therapy for Hemophilia.
    Nathwani AC; Davidoff AM; Tuddenham EGD
    Hematol Oncol Clin North Am; 2017 Oct; 31(5):853-868. PubMed ID: 28895852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future characteristics of bypassing agents to improve care of hemophilia inhibitor patients: an economic and health-related quality of life perspective.
    Weatherall J; Barnes N; Brown C; Préaud E
    Expert Rev Pharmacoecon Outcomes Res; 2011 Aug; 11(4):411-4. PubMed ID: 21831021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome measures in haemophilia: a systematic review.
    Boehlen F; Graf L; Berntorp E
    Eur J Haematol Suppl; 2014 Aug; 76():2-15. PubMed ID: 24957102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemophilia, state of the art and new therapeutic opportunities, a regulatory perspective.
    Tomeo F; Mariz S; Brunetta AL; Stoyanova-Beninska V; Penttila K; Magrelli A
    Br J Clin Pharmacol; 2021 Nov; 87(11):4183-4196. PubMed ID: 33772837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.